Christopher D. Anderson, MD, MMSc
Neurology, Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School
Program in Medical and Population Genetics, Broad Institute
Physician Investigator (Cl)
Center for Genomic Medicine, Mass General Research Institute
Acute Stroke Services, Massachusetts General Hospital
|Neurocritical Care Fellowship Massachusetts General Hospital 2012|
|MMSc Harvard Medical School 2014|
|MD Northwestern University Feinberg School of Medicine 2005|
|Neurology Residency Massachusetts General Hospital 2009|
|MD Northwestern University 2005|
|MD Northwestern University Medical School 2005|
I am a leader in the International Stroke Genetics Consortium, an organization made up of investigators from around the world devoted to using human genetics to explore the biology of stroke and derive new methods to prevent and treat cerebrovascular disease. I have been involved in many large-scale genetics efforts in ischemic and hemorrhagic stroke, leveraging variants across the human genome in thousands of participants to refine our understanding of how cerebrovascular disease develops and evolves. I share a laboratory with my research partner, Jonathan Rosand. Together, we are committed to advancing genetic discoveries in stroke towards novel biology and advanced therapeutics.
Our primary research location is in the Center for Genomic Medicine at Massachusetts General Hospital, but I am also an Associate Member of the Broad Institute in the Program in Medical and Population Genetics. At the Broad, we are working towards new methods in clinical research implementation through the use of machine learning, advanced feature recognition, and integration of genetic, imaging, and clinical information for better models of health and disease. In the future, we hope to use these tools to improve methodologies for therapeutic discovery and clinical trial implementation, improving both the cost and effectiveness of drug development.